Markets:

Overview

News

Currencies

International

Treasuries

Citius Pharmaceuticals, Inc. - Common Stock (NQ:CTXR)

0.6731 +0.0931 (+16.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Citius Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 10, 2025

Via Benzinga

Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

June 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 09, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

June 09, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Why Citius Pharmaceuticals (CTXR) Stock Is Down 15% ↗

January 08, 2025

Citius Pharmaceuticals shares are trading lower by 15% during Wednesday's session. The company announced a $3 million registered direct offering.

Via Benzinga

Which stocks are moving on Monday? ↗

June 09, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Citius Pharmaceuticals Stock Is Soaring Monday: What's Going On? ↗

June 09, 2025

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) shares are trading higher Monday after the company announced it entered into a distribution services agreement with Cardinal Health.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 09, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

June 09, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

This Pharma Company Is Preparing To Launch Its Lead Candidate

July 25, 2024

This Pharma Company Is Preparing To Launch Its Lead Candidate

Via News Direct

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

June 09, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

May 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 14, 2025

Via Benzinga

These stocks have an unusual volume in today's session ↗

April 01, 2025

Volume analysis on 2025-04-01: stocks with an unusual volume in today's session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 01, 2025

Via Benzinga

Monday's session: top gainers and losers ↗

March 31, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session. ↗

March 28, 2025

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 16, 2025

Via Benzinga

This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday ↗

December 30, 2024

Via Benzinga

US Stock Futures Slip After Friday's Fall: 'Santa Rally' In Doubt? Analyst Calls It A Bit Of Profit-Taking ↗

December 30, 2024

U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.

Via Benzinga

Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

December 30, 2024

Via Benzinga

CCSC Technology International, CEL-SCI And 3 Stocks To Watch Heading Into Monday ↗

December 30, 2024

Via Benzinga

Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗

November 27, 2024

Via Benzinga

US Stocks Mixed; Best Buy Posts Downbeat Earnings ↗

November 26, 2024

Via Benzinga

CTXR Stock Earnings: Citius Pharma Meets EPS for Q3 2024 ↗

August 12, 2024

CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection ↗

August 08, 2024

Citius Pharmaceuticals receives FDA approval for Lymphir, the first therapy targeting the IL-2 receptor in relapsed or refractory cutaneous T-cell lymphoma. U.S. market launch planned within five...

Via Benzinga

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

August 06, 2024

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

Via News Direct

Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products

July 30, 2024

Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products

Via News Direct

Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)

July 18, 2024

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second...

Via Newsfile

Analysts Hunt for Undervalued Biotech Stocks

July 17, 2024

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first...

Via Newsfile

Topics Economy Initial Public Offering

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.